When Standard Pain Treatments Fall Short, Ketamine is Stepping Up
Researchers found that IV ketamine together delivered stronger pain relief than either drug alone in patients with refractory chronic pain.
Read Morelisteo-data-scraper domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/healingmaps.imarkdev.com/wp-includes/functions.php on line 6170
Researchers found that IV ketamine together delivered stronger pain relief than either drug alone in patients with refractory chronic pain.
Read More
For the first time, researchers have captured direct brain images showing exactly how ketamine provides relief for depressed patients.
Read More
A researcher recently spent six months combing through Reddit posts from patients using at home ketamine. What he found should alarm everyone.
Read More
Reunion Neuroscience announced that its drug luvesilocin received Breakthrough Therapy Designation for the treatment of postpartum depression.
Read More
Americans are warming to psychedelics, and the shift is rooted in something deeply personal: the desire for better treatment options.
Read More
A new study from AltaPointe Health now shows that an ultra low dose of ketamine may treat fentanyl addiction.
Read More
Compass Pathways just gave the psychedelic medicine field its biggest day in years.
Read More
The study found a single low dose of ketamine reduced fatigue scores by 21% within three days. The effect peaked at 24 hours, when fatigue dropped by nearly 39%.
Read More
A new study from King's College London and the University of Exeter is challenging a popular assumption in ketamine therapy.
Read More
Monash University has delivered what no institution has before: a formal clinical practice guideline for MDMA assisted psychotherapy.
Read More